This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga·06/16 13:20
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Needham analyst Ryan MacDonald initiated coverage on Hinge Health, Inc. (NYSE:HNGE) with a Buy rating and announced a price target of $47. Hinge Health shares closed at $34.85 on Friday. See how other analysts view this stock.
Jefferies analyst Randal Konik initiated coverage on Signet Jewelers Limited (NYSE:SIG) with a Buy rating and announced a price target of $102. Signet Jewelers shares closed at $76.49 on Friday. See how other analysts view this stock.
Leerink Partners analyst Mike Kratky initiated coverage on Boston Scientific Corporation (NYSE:BSX) with an Outperform rating and announced a price target of $118. Boston Scientific shares closed at $99.74 on Friday. See how other analysts view this stock.
UBS analyst Bryan Adams initiated coverage on Conagra Brands, Inc. (NYSE:CAG) with a Neutral rating and announced a price target of $22. Conagra Brands shares closed at $21.57 on Friday. See how other analysts view this stock.
RBC Capital analyst Anthony Codling initiated coverage on Martin Marietta Materials, Inc. (NYSE:MLM) with a Sector Perform rating and announced a price target of $515. Martin Marietta Materials shares closed at $542.47 on Friday. See how other analysts view this stock.
Considering buying BSX stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.